×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Infusion Systems Market Analysis

ID: MRFR/MED/0703-CR
168 Pages
Kinjoll Dey
May 2017

Infusion System Market Research Report By Product Type (Iv Disposable, Infusion Pump, Others); By Application (Chemotherapy, Diabetes, Gastrointestinal Diseases, Pediatrics, And Others); By End User (Hospitals, Specialty Oncology Wards, Homecare) - Forecast To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Infusion Systems Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Analysis

In-depth Analysis of Infusion Systems Market Industry Landscape

The important part of the healthcare business called the "Infusion Systems Market" is going through big changes because of new technologies, more people getting chronic diseases, and an older population. One trend that stands out is the rise in demand for home IV treatment, which is driven by patients' needs for ease and low costs. Because of this change, companies are focused on making infusion devices that are easy for people to use and can be taken with them. The market is changing all the time because of new technologies. For example, smart infusion systems and devices offer better accuracy, communication, and data tracking. Putting IoT and digital health solutions together is improving patient results and making healthcare service more efficient. More and more people are getting chronic diseases like cancer and diabetes, which is driving up the demand for infusion systems. Infusion devices are very important for making sure that drugs are delivered precisely and safely to people who need long-term medicine management. Key players in the infusion systems market are increasingly merging and buying each other out as a way to stay competitive. This trend aims to improve product lines, reach more customers, and encourage new ideas by getting people to work together. A big thing that affects how markets work is the governing environment. Tough rules and laws for medical equipment, like IV systems, are making companies spend money on research and development to make sure they meet the rules and make sure their products are safe. The growing number of older people around the world is making more people want infusion devices, since older people often need long-term medical care. This change in the population is affecting market growth, with a focus on making treatment solutions that are age-appropriate and patient-centered. There are now cheaper options on the market, like reuse infusion systems, that are meant to answer worries about cost while still meeting quality and safety standards. This trend is especially important in places where finding affordable health care is very important. A focus on the patient is becoming more important in the planning and creation of infusion devices. Manufacturers are making devices easier to use by adding user-friendly displays, reducing device complexity, and improving the overall patient experience. This is done to help patients stick to their treatment plans. The world market for infusion devices is growing, with a focus on economies that are still growing. The market is growing because more people are learning about healthcare, infrastructure is getting better, and people's spending incomes are going up. This gives market players new possibilities. The market is growing in line with improving technology, more people requiring long-term treatments, and the evolving healthcare system. Players in the market need to change with these changes to stay competitive and meet the changing needs of both consumers and healthcare workers.

Author
Kinjoll Dey
Research Analyst Level I

He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Get In Touch

Leave a Comment

FAQs

What is the valuation of the global infusion systems market?

The global infusion systems market valuation is expected at USD 12.81 Millionby 2032.

What is the expected growth rate of the global infusion systems market?

The global infusion systems market is expected to grow at 8.9% CAGR from 2023-2032.

What are the main growth drivers of the global infusion systems market?

Technological breakthroughs from market leaders, demand of infusion units in the military, and prevalence of chronic diseases are major drivers of the global infusion systems market.

What are challenges facing the global infusion systems market?

Unmet medical needs in low-income countries and concerns regarding infusion are major challenges of the global infusion systems market.

Which region will dominate the global infusions systems market?

North America will dominate the global infusion systems market and will fetch close to USD 15.79 billion by 2025.

Which region can generate revenue the fastest in the global infusion systems market?

APAC is predicted to generate the fastest revenue for the global infusion systems market at a CAGR of 8.90% from 2022 to 2030.

Name the leaders of the global infusion systems market.

Terumo Medical Corporation, Becton, Dickinson and Company, ICU Medical, Inc, Fresenius Kabi AG, Smiths Medical, B. BRAUN MELSUNGEN AG, 3M, and Baxter are major players of the global infusion systems market.

Market Summary

As per MRFR analysis, the Infusion Systems Market Size was estimated at 19.74 USD Billion in 2024. The Infusion Systems industry is projected to grow from 21.42 USD Billion in 2025 to 43.17 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.33% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Infusion Systems Market is experiencing robust growth driven by technological advancements and increasing demand for home healthcare solutions.

  • Technological advancements are enhancing the efficiency and safety of infusion systems, particularly in North America. The rising demand for home healthcare is propelling growth in the infusion systems market, especially in the Asia-Pacific region. Oncology remains the largest segment, while pain management is emerging as the fastest-growing segment in infusion systems. Key market drivers include the increasing prevalence of chronic diseases and a focus on patient-centric care, which are shaping market dynamics.

Market Size & Forecast

2024 Market Size 19.74 (USD Billion)
2035 Market Size 43.17 (USD Billion)
CAGR (2025 - 2035) 7.33%
Largest Regional Market Share in 2024 North America

Major Players

<p>Baxter International (US), <a href="https://www.bbraun.com/en/products-and-solutions/therapies/infusion-therapy.html">B. Braun Melsungen AG</a> (DE), <a href="https://www.medtronic.com/en-us/healthcare-professionals/products/neurological/drug-infusion-systems.html">Medtronic </a>(US), Smiths Medical (US), <a href="https://www.fresenius-kabi.com/en-ca/products/infusion-technology">Fresenius Kabi</a> (DE), Terumo Corporation (JP), ICU Medical (US), Halyard Health (US), C.R. Bard (US)</p>

Market Trends

The Infusion Systems Market is currently experiencing a transformative phase characterized by advancements in technology and increasing demand for efficient healthcare solutions. The integration of smart technologies into infusion systems appears to enhance patient safety and improve clinical outcomes. Moreover, the growing prevalence of chronic diseases necessitates the adoption of sophisticated infusion devices, which could potentially streamline treatment protocols and reduce hospital stays. As healthcare providers seek to optimize resource utilization, the infusion systems landscape is likely to evolve, incorporating features such as remote monitoring and data analytics to facilitate better decision-making. In addition, the emphasis on personalized medicine is influencing the Infusion Systems Market, as tailored therapies require precise delivery mechanisms. This trend suggests a shift towards more versatile and adaptable infusion devices that can cater to individual patient needs. Furthermore, regulatory bodies are increasingly focusing on ensuring the safety and efficacy of infusion systems, which may lead to enhanced standards and practices within the industry. Overall, the Infusion Systems Market is poised for growth, driven by innovation and a commitment to improving patient care.

Technological Advancements

The infusion systems sector is witnessing rapid technological innovations, particularly in the realm of smart infusion pumps. These devices are increasingly equipped with features such as dose error reduction systems and wireless connectivity, which enhance their functionality and safety. Such advancements are likely to improve the overall efficiency of infusion therapies.

Rising Demand for Home Healthcare

There is a noticeable shift towards home healthcare solutions, driven by patient preferences for receiving treatment in familiar environments. This trend is prompting manufacturers to develop portable and user-friendly infusion systems that can be utilized outside traditional clinical settings, thereby expanding market reach.

Focus on Patient Safety

The Infusion Systems Market is placing greater emphasis on patient safety, with manufacturers prioritizing the development of devices that minimize the risk of medication errors. Enhanced training programs and improved user interfaces are being implemented to ensure that healthcare professionals can operate these systems effectively, thereby safeguarding patient well-being.

Infusion Systems Market Market Drivers

Rising Healthcare Expenditure

Healthcare expenditure continues to rise globally, influencing the Global Infusion System Market Industry. Increased investment in healthcare infrastructure and services leads to enhanced access to advanced medical technologies, including infusion systems. Governments and private sectors are allocating substantial resources to improve healthcare delivery, which in turn drives the demand for effective infusion solutions. As healthcare systems evolve, the focus on patient-centered care and efficient treatment modalities becomes paramount. This trend is likely to sustain the market's growth trajectory, as stakeholders prioritize investments in innovative infusion technologies to meet the growing healthcare demands.

Regulatory Support and Standards

Regulatory bodies play a pivotal role in shaping the Global Infusion System Market Industry. The establishment of stringent safety and efficacy standards for infusion devices ensures that only high-quality products reach the market. This regulatory support fosters innovation and encourages manufacturers to develop advanced infusion systems that meet evolving healthcare needs. Compliance with these regulations not only enhances patient safety but also builds trust among healthcare providers and patients. As the market continues to expand, the emphasis on regulatory compliance will likely drive the development of safer and more effective infusion technologies.

Rising Prevalence of Chronic Diseases

The Global Infusion System Market Industry is witnessing a surge in demand due to the increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders. As of 2024, the market is valued at approximately 5.49 USD Billion, reflecting the urgent need for effective treatment options. Infusion systems play a crucial role in managing these conditions, providing precise medication delivery and improving patient outcomes. The growing aging population further exacerbates this trend, as older individuals are more susceptible to chronic illnesses. This demographic shift suggests that the market will continue to expand, driven by the need for advanced infusion technologies.

Technological Advancements in Infusion Systems

Technological innovations are significantly shaping the Global Infusion System Market Industry. The introduction of smart infusion pumps, which offer features like dose error reduction systems and wireless connectivity, enhances patient safety and treatment efficacy. These advancements are likely to increase the adoption of infusion systems across healthcare settings. The market is projected to grow at a compound annual growth rate of 10.55% from 2025 to 2035, indicating a robust demand for these technologies. As healthcare providers seek to improve operational efficiency and patient care, the integration of advanced technologies into infusion systems becomes increasingly vital.

Increasing Demand for Home Healthcare Solutions

The Global Infusion System Market Industry is experiencing a notable shift towards home healthcare solutions. Patients are increasingly opting for home-based treatments due to the convenience and comfort they offer. Infusion systems designed for home use enable patients to receive necessary therapies without frequent hospital visits. This trend is particularly relevant for chronic disease management, where continuous treatment is essential. As the market evolves, the demand for portable and user-friendly infusion devices is expected to rise, contributing to the overall market growth. The projected market value of 16.5 USD Billion by 2035 underscores the potential of this segment.

Market Segment Insights

By Application: Oncology (Largest) vs. Pain Management (Fastest-Growing)

<p>In the Infusion Systems Market, Oncology is recognized as the largest segment, driven by the increasing incidence of cancer and the demand for effective treatment options. Conversely, <a href="https://www.marketresearchfuture.com/reports/pain-management-market-5975">Pain Management</a> is gaining traction, reflecting a notable increase in the number of patients requiring pain relief and management solutions. This distribution indicates a dynamic market landscape aimed at addressing diverse patient needs across various applications.</p>

<p>Oncology (Dominant) vs. Pain Management (Emerging)</p>

<p>Oncology remains a dominant force within the infusion systems arena, characterized by advanced technologies supporting chemotherapy treatments. Healthcare providers rely heavily on infusion systems for precise dosing, enhanced patient safety, and customization to individual treatment regimens. On the other hand, Pain Management is emerging as a rapidly growing segment, fueled by rising awareness and recognition of chronic pain conditions. The integration of infusion systems within pain management allows for continuous delivery of analgesics, which is gaining significant acceptance among clinicians and patients alike, positioning it as a pivotal area for future growth.</p>

By End Use: Hospitals (Largest) vs. Home Care (Fastest-Growing)

<p>In the infusion systems market, hospitals remain the largest end-use segment, accounting for a significant share of the total market. The need for comprehensive patient care, advanced technology, and high-volume procedures contributes to hospitals commanding a major portion of the market. Home care, on the other hand, is quickly gaining traction with an increasing demand for at-home health management solutions and consumer preference for receiving care in familiar environments.</p>

<p>Hospitals (Dominant) vs. Home Care (Emerging)</p>

<p>Hospitals are characterized by their reliance on sophisticated infusion systems to manage a wide range of patient treatments, from acute care to chronic illness management. The growing focus on patient-centered care models drives the demand for highly efficient and reliable infusion technologies. In contrast, home care is emerging as a significant player in the infusion systems market, fueled by advancements in portable infusion devices and the trend of managing health conditions outside traditional settings. This segment caters to patients seeking independence in their treatments, emphasizing convenience and personalized care. The convergence of technology and patient needs positions home care as a rapidly expanding segment, appealing to a demographic that values accessibility and flexibility.</p>

By Product Type: Infusion Pumps (Largest) vs. Infusion Sets (Fastest-Growing)

<p>In the Infusion Systems Market, Infusion Pumps dominate the product type segment with a substantial market share, reflecting their critical role in delivering precise medication dosages. Infusion Sets follow closely, providing essential connectivity and functionality for pumps, while IV Accessories and Syringe Pumps fill supporting roles in this ecosystem. This distribution signals the importance of reliable core technologies in healthcare settings, particularly hospitals and home healthcare environments. The growth trends within this segment are primarily driven by advancements in technology and rising demand for efficient drug delivery systems. Infusion Pumps are continuously evolving, integrating smart technologies for data tracking and patient safety, thereby enhancing their appeal and adoption in various clinical settings. Similarly, the emergence of Infusion Sets as the fastest-growing segment underscores their increasing importance due to bolstered healthcare regulations and the need for effective and reliable drug administration solutions.</p>

<p>Infusion Pumps (Dominant) vs. Syringe Pumps (Emerging)</p>

<p>Infusion Pumps are recognized as the dominant segment within the Infusion Systems Market due to their robust operational capabilities and widespread acceptance in various medical applications, including critical care and pain management. Their advanced features such as programmable settings and safety mechanisms make them a preferred choice among healthcare providers. Conversely, Syringe Pumps are considered an emerging technology that caters to a specific niche, notably in scenarios requiring precise dosage for small volumes of medications. The increasing demand for outpatient treatments and advancements in syringe pump technology, such as compact designs and improved accuracy, contribute to their growing market presence. The collaborative use of both devices enhances overall patient care, allowing for tailored treatment strategies.</p>

By Technology: Volumetric Infusion Systems (Largest) vs. Smart Infusion Systems (Fastest-Growing)

<p>In the Infusion Systems Market, Volumetric Infusion Systems hold a significant market share, showcasing their reliability and effectiveness in delivering precise medication dosages. This established technology has become a staple in clinical settings, attributed to its efficiency and proven track record. Meanwhile, Smart Infusion Systems are rapidly gaining traction, indicating a shift towards advanced technology that enhances safety and patient management through integrated software solutions.</p>

<p>Technology: Volumetric Infusion Systems (Dominant) vs. Smart Infusion Systems (Emerging)</p>

<p>Volumetric Infusion Systems dominate the market landscape due to their longstanding presence and trusted performance, making them the go-to choice in various healthcare settings. They excel in delivering accurate volumes of fluids and medications, thereby ensuring patient safety. In contrast, Smart Infusion Systems are on an upward trajectory, leveraging technology to offer features such as automated drug delivery and integration with electronic health records. These systems not only improve infusion accuracy but also enhance clinician workflow by providing alerts and data analytics, positioning them as the emerging technology within the infusion systems domain.</p>

By Patient Type: Adult Patients (Largest) vs. Pediatric Patients (Fastest-Growing)

<p>In the Infusion Systems Market, adult patients account for the largest share, driven by the increasing prevalence of chronic diseases that necessitate regular infusion therapy. A significant number of infusion procedures are performed on adults, particularly in oncology and diabetes management, highlighting the importance of this demographic. Meanwhile, pediatric patients represent the fastest-growing segment as healthcare providers focus on specialized infusion systems tailored to younger age groups. Efforts to enhance safety and efficacy in administering therapies to children are propelling this segment's growth.</p>

<p>Patient Type: Adult Patients (Dominant) vs. Pediatric Patients (Emerging)</p>

<p>Adult patients dominate the Infusion Systems Market due to the rising incidence of chronic conditions that require continuous treatment through infusion methods. The technology used in adult infusion systems is often more advanced and robust, reflecting the complexity of therapies administered to this demographic. Conversely, pediatric patients represent an emerging segment, with increased demand for adaptable and child-friendly infusion systems. Market players are innovating to create systems that not only ensure precise dosing but also cater to the unique physiological needs of children, thereby enhancing both safety and treatment outcomes.</p>

Get more detailed insights about Infusion System Market Research Report- Forecast To 2035

Regional Insights

North America : Market Leader in Infusion Systems

North America is poised to maintain its leadership in the infusion systems market, holding a significant share of 9.87 in 2024. The region's growth is driven by increasing healthcare expenditures, technological advancements, and a rising prevalence of chronic diseases. Regulatory support from agencies like the FDA further catalyzes innovation and market expansion, ensuring that North America remains at the forefront of infusion technology development. The competitive landscape in North America is robust, featuring key players such as Baxter International, Medtronic, and ICU Medical. These companies are investing heavily in R&D to enhance product offerings and improve patient outcomes. The presence of advanced healthcare infrastructure and a high demand for home healthcare solutions are also contributing to the region's market growth, making it a focal point for infusion system innovations.

Europe : Emerging Market with Growth Potential

Europe's infusion systems market is valued at 5.92, reflecting a growing demand driven by an aging population and increasing chronic disease prevalence. Regulatory frameworks, such as the EU Medical Device Regulation, are enhancing product safety and efficacy, thereby boosting consumer confidence. The region is also witnessing a shift towards outpatient care, which is expected to further drive the demand for advanced infusion systems. Leading countries in Europe include Germany, France, and the UK, where major players like B. Braun Melsungen AG and Fresenius Kabi are actively expanding their market presence. The competitive landscape is characterized by strategic partnerships and collaborations aimed at innovation. As healthcare systems evolve, the infusion systems market in Europe is set to experience significant growth, supported by technological advancements and regulatory improvements.

Asia-Pacific : Rapid Growth in Healthcare Sector

The Asia-Pacific infusion systems market, valued at 3.45, is experiencing rapid growth due to increasing healthcare investments and a rising prevalence of chronic diseases. Countries like China and India are witnessing significant healthcare reforms, which are enhancing access to advanced medical technologies. The region's regulatory bodies are also becoming more stringent, ensuring that products meet international safety standards, thus driving market growth. Key players such as Terumo Corporation and Smiths Medical are expanding their footprint in this region, capitalizing on the growing demand for infusion systems. The competitive landscape is marked by local manufacturers emerging alongside established global players, creating a dynamic market environment. As healthcare infrastructure improves, the Asia-Pacific region is expected to become a major hub for infusion system innovations and applications.

Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa (MEA) infusion systems market is valued at 0.5, reflecting emerging opportunities amidst various challenges. The region is witnessing a gradual increase in healthcare spending, driven by government initiatives aimed at improving healthcare infrastructure. However, regulatory hurdles and market access issues remain significant barriers to growth. The demand for infusion systems is expected to rise as healthcare facilities expand and modernize. Countries like South Africa and the UAE are leading the way in adopting advanced medical technologies, with key players such as Halyard Health and C.R. Bard establishing a presence in the region. The competitive landscape is evolving, with local manufacturers beginning to enter the market. As the MEA region continues to develop its healthcare capabilities, the infusion systems market is likely to see substantial growth in the coming years.

Key Players and Competitive Insights

The Infusion Systems Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and an increasing demand for efficient healthcare solutions. Key players such as Baxter International (US), B. Braun Melsungen AG (DE), and Medtronic (US) are strategically positioned to leverage innovation and expand their market presence. Baxter International (US) focuses on enhancing its product portfolio through continuous innovation, while B. Braun Melsungen AG (DE) emphasizes regional expansion and partnerships to strengthen its foothold in emerging markets. Medtronic (US) is actively pursuing digital transformation initiatives, which collectively shape a competitive environment that is increasingly reliant on technological prowess and strategic collaborations.

In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for a diverse range of products and services, fostering competition that drives innovation and quality improvements across the board.

In November 2025, Baxter International (US) announced the launch of a new infusion pump designed to integrate seamlessly with electronic health records (EHRs). This strategic move is significant as it not only enhances patient safety through improved data accuracy but also positions Baxter as a leader in the digital integration of infusion systems. The ability to connect infusion devices with EHRs reflects a growing trend towards interoperability in healthcare technology.

In October 2025, B. Braun Melsungen AG (DE) expanded its manufacturing capabilities in Asia by opening a new facility in Vietnam. This expansion is crucial as it allows the company to meet the rising demand for infusion systems in the Asia-Pacific region, which is experiencing rapid growth. By localizing production, B. Braun can reduce lead times and costs, thereby enhancing its competitive edge in a price-sensitive market.

In September 2025, Medtronic (US) entered into a strategic partnership with a leading AI technology firm to develop smart infusion systems that utilize machine learning algorithms. This collaboration is indicative of the increasing integration of AI in healthcare, aiming to improve dosing accuracy and patient outcomes. Such innovations are likely to redefine the standards of care in infusion therapy, positioning Medtronic at the forefront of this technological evolution.

As of December 2025, the competitive trends in the Infusion Systems Market are increasingly defined by digitalization, sustainability, and AI integration. Strategic alliances are becoming pivotal in shaping the landscape, as companies seek to combine their strengths to innovate and enhance service delivery. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition towards a focus on innovation, technology, and supply chain reliability. This shift underscores the necessity for companies to adapt and invest in advanced technologies to maintain a competitive advantage.

Key Companies in the Infusion Systems Market market include

Industry Developments

  • Q2 2024: New platform creation exploded in 2024 with 11 announced platform deals, which was significantly more than in 2023 and 2022 combined. The infusion therapy sector saw a record number of platform M&A deals in 2024, with 11 new platforms announced, indicating increased consolidation and future add-on acquisition activity in the infusion system market.
  • Q2 2024: By far the largest acquirer in terms of announced deals since 2019 is publicly-traded Option Care, with eight. Option Care emerged as the most active acquirer in the infusion therapy market, having completed eight announced deals since 2019, with significant activity continuing into 2024.

Future Outlook

Infusion Systems Market Future Outlook

<p>The Infusion Systems Market is projected to grow at a 7.33% CAGR from 2024 to 2035, driven by technological advancements, increasing chronic diseases, and rising healthcare expenditures.</p>

New opportunities lie in:

  • <p>Development of smart infusion pumps with integrated IoT capabilities.</p>
  • <p>Expansion of home healthcare infusion services to enhance patient convenience.</p>
  • <p>Partnerships with <a href="https://www.marketresearchfuture.com/reports/telehealth-market-900">telehealth </a>platforms for remote patient monitoring solutions.</p>

<p>By 2035, the Infusion Systems Market is expected to achieve substantial growth, reflecting evolving healthcare demands.</p>

Market Segmentation

Infusion Systems Market End Use Outlook

  • Hospitals
  • Home Care
  • Ambulatory Surgical Centers
  • Specialty Clinics

Infusion Systems Market Technology Outlook

  • Volumetric Infusion Systems
  • Smart Infusion Systems
  • Gravity Infusion Systems

Infusion Systems Market Application Outlook

  • Oncology
  • Pediatrics
  • Pain Management
  • Antibiotic Therapy
  • Nutritional Support

Infusion Systems Market Patient Type Outlook

  • Adult Patients
  • Pediatric Patients
  • Geriatric Patients

Infusion Systems Market Product Type Outlook

  • Infusion Pumps
  • Infusion Sets
  • IV Accessories
  • Syringe Pumps

Report Scope

MARKET SIZE 2024 19.74(USD Billion)
MARKET SIZE 2025 21.42(USD Billion)
MARKET SIZE 2035 43.17(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.33% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Baxter International (US), B. Braun Melsungen AG (DE), Medtronic (US), Smiths Medical (US), Fresenius Kabi (DE), Terumo Corporation (JP), ICU Medical (US), Halyard Health (US), C.R. Bard (US)
Segments Covered Application, End Use, Product Type, Technology, Patient Type
Key Market Opportunities Integration of smart technology in Infusion Systems Market enhances patient safety and treatment efficiency.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the infusion systems market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the valuation of the global infusion systems market?

The global infusion systems market valuation is expected at USD 12.81 Millionby 2032.

What is the expected growth rate of the global infusion systems market?

The global infusion systems market is expected to grow at 8.9% CAGR from 2023-2032.

What are the main growth drivers of the global infusion systems market?

Technological breakthroughs from market leaders, demand of infusion units in the military, and prevalence of chronic diseases are major drivers of the global infusion systems market.

What are challenges facing the global infusion systems market?

Unmet medical needs in low-income countries and concerns regarding infusion are major challenges of the global infusion systems market.

Which region will dominate the global infusions systems market?

North America will dominate the global infusion systems market and will fetch close to USD 15.79 billion by 2025.

Which region can generate revenue the fastest in the global infusion systems market?

APAC is predicted to generate the fastest revenue for the global infusion systems market at a CAGR of 8.90% from 2022 to 2030.

Name the leaders of the global infusion systems market.

Terumo Medical Corporation, Becton, Dickinson and Company, ICU Medical, Inc, Fresenius Kabi AG, Smiths Medical, B. BRAUN MELSUNGEN AG, 3M, and Baxter are major players of the global infusion systems market.

  1. Report Prologue
  2. Market Introduction
    1. Definition
    2. Scope of Study
    3. Research Objective
    4. Assumptions & Limitations
      1. Assumptions
      2. Limitations
    5. Market Structure
  3. Research Methodology
    1. Research Process
    2. Primary Research
    3. Secondary Research
    4. Market Size Estimation
    5. Forecast Model
  4. Market Dynamics
    1. Introduction
    2. Drivers
      1. Increased Use of Infusion Pumps for the Delivery of Drugs and Other Fluids.
      2. Rising Prevalence of Chronic and Fatal Diseases
      3. High Demand of the Infusion Systems in the Military Medical Units.
      4. Technological Advancements from the Leading Market Players
    3. Restraint
      1. Patient Safety Concerns and Improper Infusion Leading to the Severe Consequences.
      2. Unmet Medical Needs in the Low Income Countries
    4. Opportunity
      1. Growing Geriatric Population Presents Significant Growth Opportunity
      2. Low Income Economies and Developing Nations With Improving Healthcare Facilities Present a Great Opportunity.
    5. Macroeconomic Indicators
    6. Mega Trends
  5. Market Factor Analysis
    1. Value Chain Analysis
      1. Research & Product Development
      2. Component Manufacturing
      3. Assembly
      4. Distribution
    2. Porters Five Forces Model
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
    3. Demand,Supply, and Gap Analysis
      1. Demand Side Factors
      2. Supply Side Factors
      3. Gap Closing Strategies
    4. Pricing Analysis
    5. Investment Opportunities
    6. Merger & Acquisition Landscape
    7. Upcoming Trends
  6. Infusion System Market, By Product Type
    1. Introduction
    2. IV Disposable
    3. Infusion Pump
      1. Volumetric Pump
      2. Ambulatory Pump
      3. Syringe Pump
  7. Infusion System Market, By Application
    1. Introduction
    2. Chemotherapy
    3. Diabetes
    4. Gastrointestinal Disorders
    5. Pediatrics
    6. Other Applications
  8. Infusion System Market, By End User
    1. Introduction
    2. Hospitals
    3. Specialty Oncology Wards
    4. Homecare
  9. Global Infusion System Market, By Region
    1. Introduction
    2. North America
  10. Infusion System Market, By Product Type
  11. Infusion System Market, By Application
  12. Infusion System Market, By End User
  13. Introduction
  14. US
  15. Infusion System Market, By Product Type
  16. Infusion System Market, By Application
  17. Infusion System Market, By End User
  18. Canada
  19. Infusion System Market, By Product Type
  20. Infusion System Market, By Application
  21. Infusion System Market, By End User
    1. Europe
  22. Infusion System Market, By Product Type
  23. Infusion System Market, By Application
  24. Infusion System Market, By End User
  25. Introduction
  26. Germany
  27. Infusion System Market, By Product Type
  28. Infusion System Market, By Application
  29. Infusion System Market, By End User
  30. France
  31. Infusion System Market, By Product Type
  32. Infusion System Market, By Application
  33. Infusion System Market, By End User
  34. UK
  35. Infusion System Market, By Product Type
  36. Infusion System Market, By Application
  37. Infusion System Market, By End User
  38. Italy
  39. Infusion System Market, By Product Type
  40. Infusion System Market, By Application
  41. Infusion System Market, By End User
  42. Spain
  43. Infusion System Market, By Product Type
  44. Infusion System Market, By Application
  45. Infusion System Market, By End User
  46. Rest Of Western Europe
  47. Infusion System Market, By Product Type
  48. Infusion System Market, By Application
  49. Infusion System Market, By End User
  50. EASTERN EUROPE
  51. Infusion System Market, By Product Type
  52. Infusion System Market, By Application
  53. Infusion System Market, By End User
    1. Asia-Pacific
  54. Infusion System Market, By Product Type
  55. Infusion System Market, By Application
  56. Infusion System Market, By End User
  57. Introduction
  58. Japan
  59. Infusion System Market, By Product Type
  60. Infusion System Market, By Application
  61. Infusion System Market, By End User
  62. China
  63. Infusion System Market, By Product Type
  64. Infusion System Market, By Application
  65. Infusion System Market, By End User
  66. India
  67. Infusion System Market, By Product Type
  68. Infusion System Market, By Application
  69. Infusion System Market, By End User
  70. REPUBLIC OF KOREA
  71. Infusion System Market, By Product Type
  72. Infusion System Market, By Application
  73. Infusion System Market, By End User
  74. Australia
  75. Infusion System Market, By Product Type
  76. Infusion System Market, By Application
  77. Infusion System Market, By End User
  78. Rest of Asia-Pacific
  79. Infusion System Market, By Product Type
  80. Infusion System Market, By Application
  81. Infusion System Market, By End User
    1. Middle East & Africa
  82. Infusion System Market, By Product Type
  83. Infusion System Market, By Application
  84. Infusion System Market, By End User
  85. Introduction
  86. Middle East
  87. Infusion System Market, By Product Type
  88. Infusion System Market, By Application
  89. Infusion System Market, By End User
  90. Africa
  91. Infusion System Market, By Product Type
  92. Infusion System Market, By Application
  93. Infusion System Market, By End User
  94. Company Landscape
    1. Company Share Analysis
    2. Competitive Landscape
      1. Product Launch/Development
      2. Partnerships & Collaborations
      3. Acquisition
    3. Current Market Driving Player & Their Strategies
  95. Company Profile
    1. 3M
      1. Overview
      2. Product Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
    2. Baxter
      1. Company Overview
      2. Product/Business Segment Overview
      3. Financial Overview
      4. Key Development
      5. SWOT Analysis
    3. Becton, Dickinson and Company
      1. Overview
      2. Product/Business Segment Overview
      3. Financial Updates
      4. Key Developments
      5. SWOT Analysis
    4. B. Braun Melsungen AG
      1. Overview
      2. Product/Business Segment Overview
      3. Financial Overview
      4. Key Development
      5. SWOT Analysis
    5. Fresenius Kabi AG
      1. Company Overview
      2. Product/Business Segment Overview
      3. Financial Overview
      4. Key Development
      5. SWOT Analysis
    6. ICU Medical, Inc
      1. Company overview
      2. Product Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    7. Smiths Medical
      1. Company Overview
      2. Product Overview
      3. Financial Overview
      4. Key Developments
      5. S.W.O.T
    8. Terumo Medical Corporation
      1. Company Overview
      2. Product Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
    9. NIPRO Medical Corporation
      1. Company overview
      2. Product Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    10. Zyno Medical
      1. Company Overview
      2. Product Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
  96. Conclusion
    1. Key Findings
      1. CEO’s Viewpoint
      2. Unmet Needs
      3. Key Companies to Watch
      4. Prediction
  97. Appendix
    1. Discussion Blue Print
    2. References
  98. List of Tables
  99. GROWTH DRIVERS: IMPACT ANALYSIS 25
  100. PRICING RANGE OF PUMPS 35
  101. GLOBAL INFUSION SYSTEM MARKET BY PRODUCT TYPE, 2020-2027 (USD MILLION) 41
  102. GLOBAL INFUSION SYSTEM IV DISPOSABLE MARKET BY REGION, 2020-2027 (USD MILLION) 42
  103. GLOBAL INFUSION PUMP MARKET BY REGION, 2020-2027 (USD MILLION) 44
  104. GLOBAL INFUSION SYSTEM MARKET BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 44
  105. GLOBAL VOLUMETRIC PUMP MARKET BY REGION, 2020-2027 (USD MILLION) 45
  106. GLOBAL AMBULATORY PUMP MARKET BY REGION, 2020-2027 (USD MILLION) 45
  107. GLOBAL SYRINGE PUMP MARKET BY REGION, 2020-2027 (USD MILLION) 46
  108. GLOBAL IV DISPOSABLE MARKET BY APPLICATION, 2020-2027 (USD MILLION) 48
  109. GLOBAL INFUSION PUMP MARKET BY APPLICATION, 2020-2027 (USD MILLION) 49
  110. GLOBAL IV DISPOSABLE MARKET FOR CHEMOTHERAPY BY REGION, 2020-2027 (USD MILLION) 50
  111. GLOBAL INFUSION PUMP MARKET BY CHEMOTHERAPY BY REGION, 2020-2027 (USD MILLION) 51
  112. GLOBAL IV DISPOSABLE MARKET FOR DIABETES BY REGION, 2020-2027 (USD MILLION) 52
  113. GLOBAL INFUSION PUMP MARKET BY DIABETES BY REGION, 2020-2027 (USD MILLION) 52
  114. GLOBAL IV DISPOSABLE MARKET FOR GASTROINTESTINAL DISEASES BY REGION, 2020-2027 (USD MILLION) 53
  115. GLOBAL INFUSION PUMP MARKET BY GASTROINTESTINAL DISEASES BY REGION, 2020-2027 (USD MILLION) 54
  116. GLOBAL IV DISPOSABLE MARKET FOR PEDIATRICS BY REGION, 2020-2027 (USD MILLION) 55
  117. GLOBAL INFUSION PUMP MARKET BY PEDIATRICS BY REGION, 2020-2027 (USD MILLION) 55
  118. GLOBAL INFUSION SYSTEM MARKET BY END USER, 2020-2027 (USD MILLION) 57
  119. GLOBAL INFUSION SYSTEM MARKET FOR HOSPITALS BY REGION, 2020-2027 (USD MILLION) 58
  120. GLOBAL INFUSION SYSTEM MARKET FOR SPECIALTY ONCOLOGY WARDS BY REGION, 2020-2027 (USD MILLION) 59
  121. GLOBAL INFUSION SYSTEM MARKET FOR HOMECARE BY REGION, 2020-2027 (USD MILLION) 60
  122. GLOBAL INFUSION SYSTEM MARKET, BY REGION, 2020-2027 (USD MILLION) 62
  123. NORTH AMERICA INFUSION SYSTEM MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 64
  124. NORTH AMERICA INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 64
  125. NORTH AMERICA INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 65
  126. NORTH AMERICA IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 65
  127. NORTH AMERICA INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 66
  128. NORTH AMERICA INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 66
  129. US INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 67
  130. US INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 67
  131. US IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 68
  132. US INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 68
  133. US INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 69
  134. CANADA INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 69
  135. CANADA INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 70
  136. CANADA IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 70
  137. CANADA INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 71
  138. CANADA INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 71
  139. EUROPE INFUSION SYSTEM MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 73
  140. EUROPE INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 74
  141. EUROPE IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 74
  142. EUROPE INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 75
  143. EUROPE INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 75
  144. GERMANY INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 76
  145. GERMANY IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 76
  146. GERMANY INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 77
  147. GERMANY INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 77
  148. FRANCE INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 78
  149. FRANCE IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 78
  150. FRANCE INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 78
  151. FRANCE INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 79
  152. UK INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 80
  153. UK IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 80
  154. UK INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 81
  155. UK INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 81
  156. ITALY INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 82
  157. ITALY IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 82
  158. ITALY INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 83
  159. ITALY INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 83
  160. SPAIN INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 84
  161. SPAIN IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 84
  162. SPAIN INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 85
  163. SPAIN INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 85
  164. REST OF WESTERN EUROPE INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 86
  165. REST OF WESTERN EUROPE IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 86
  166. REST OF WESTERN EUROPE INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 87
  167. REST OF WESTERN EUROPE INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 87
  168. EASTERN EUROPE INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 88
  169. EASTERN EUROPE IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 88
  170. EASTERN EUROPE INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 89
  171. EASTERN EUROPE INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 89
  172. ASIA-PACIFIC INFUSION SYSTEM MARKET SHARE BY COUNTRY, 2020 (%) 90
  173. ASIA-PACIFIC INFUSION SYSTEM MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 91
  174. ASIA-PACIFIC INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 91
  175. ASIA PACIFIC INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 92
  176. ASIA-PACIFIC IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 92
  177. ASIA-PACIFIC INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 93
  178. ASIA-PACIFIC INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 93
  179. JAPAN INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 94
  180. JAPAN INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 94
  181. JAPAN IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 95
  182. JAPAN INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 95
  183. JAPAN INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 96
  184. CHINA INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 96
  185. CHINA INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 97
  186. CHINA IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 97
  187. CHINA INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 98
  188. CHINA INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 98
  189. INDIA INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 99
  190. INDIA INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 99
  191. INDIA IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 100
  192. INDIA INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 100
  193. INDIA INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 101
  194. REPUBLIC OF KOREA INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 101
  195. REPUBLIC OF KOREA INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 102
  196. REPUBLIC OF KOREA IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 102
  197. REPUBLIC OF KOREA INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 103
  198. REPUBLIC OF KOREA INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 103
  199. AUSTRALIA INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 104
  200. AUSTRALIA INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 104
  201. AUSTRALIA IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 105
  202. AUSTRALIA INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 105
  203. AUSTRALIA INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 106
  204. REST OF ASIA-PACIFIC INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 106
  205. ROA INFUSION SYSTEM MARKET, BY INFUSION PUMP TYPE, 2020-2027 (USD MILLION) 107
  206. REST OF ASIA-PACIFIC IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 107
  207. REST OF ASIA-PACIFIC INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 108
  208. REST OF ASIA-PACIFIC INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 108
  209. MIDDLE EAST & AFRICA INFUSION SYSTEM MARKET, BY REGION, 2020-2027 (USD MILLION) 109
  210. MIDDLE EAST & AFRICA INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 110
  211. MIDDLE EAST & AFRICA IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 110
  212. MIDDLE EAST & AFRICA INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 111
  213. MIDDLE EAST & AFRICA INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 111
  214. MIDDLE EAST INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 112
  215. MIDDLE EAST IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 112
  216. MIDDLE EAST INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 113
  217. MIDDLE EAST INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 113
  218. AFRICA INFUSION SYSTEM MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 114
  219. AFRICA IV DISPOSABLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 114
  220. AFRICA INFUSION PUMP MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 115
  221. AFRICA INFUSION SYSTEM MARKET, BY END USER, 2020-2027 (USD MILLION) 115
  222. BAXTER: KEY DEVELOPMENT 130
  223. BRAUN MELSUNGEN AG: KEY DEVELOPMENT 137
  224. FRESENIUS KABI AG: KEY DEVELOPMENT 141
  225. List of Figures
  226. GLOBAL INFUSION SYSTEM MARKET SHARE, BY PRODUCT TYPE, 2020 (%) 13
  227. GLOBAL IV DISPOSABLE MARKET SHARE, BY APPLICAION, 2020 (%) 14
  228. GLOBAL INFUSION PUMP MARKET SHARE, BY APPLICAION, 2020 (%) 14
  229. GLOBAL INFUSION SYSTEM MARKET SHARE, BY END USER, 2020 (%) 15
  230. GLOBAL INFUSION SYSTEM MARKET SHARE, BY REGION, 2020 (%) 16
  231. MARKET STRUCTURE OF GLOBAL INFUSION SYSTEM MARKET 18
  232. RESEARCH PROCESS 19
  233. GLOBAL INFUSION SYSTEM MARKET: MARKET DYNAMICS 22
  234. VALUE CHAIN: INFUSION SYSTEM DENTAL IMAGING MARKET 30
  235. PORTERS FIVE FORCES MODEL 31
  236. GLOBAL INFUSION SYSTEM MARKET SHARE BY PRODUCT TYPE, 2020 (%) 40
  237. GLOBAL IV DISPOSABLE MARKET SHARE BY APPLICATION, 2020 (%) 47
  238. GLOBAL INFUSION PUMP MARKET SHARE BY APPLICATION, 2020 (%) 48
  239. GLOBAL INFUSION SYSTEM MARKET SHARE BY END USER, 2020 (%) 57
  240. GLOBAL INFUSION SYSTEM MARKET SHARE, BY REGION, 2020 (%) 61
  241. NORTH AMERICA INFUSION SYSTEM MARKET SHARE BY COUNTRY, 2020 (%) 63
  242. EUROPE INFUSION SYSTEM MARKET SHARE BY COUNTRY, 2020 (%) 73
  243. MIDDLE EAST & AFRICA INFUSION SYSTEM MARKET SHARE BY REGION, 2020 (%) 109
  244. GLOBAL INFUSION SYSTEM COMPANY SHARE ANALYSIS, 2020 (%) 116
  245. 3M: RECENT FINANCIALS 124
  246. 3M: SEGMENTAL REVENUE 124
  247. 3M: GEOGRAPHICAL REVENUE 125
  248. 3M: SWOT ANALYSIS 126
  249. BAXTER: RECENT FINANCIAL 128
  250. BAXTER: HISTORICAL SEGMENTAL REVENUE (USD MILLION) 128
  251. BAXTER: GEOGRAPHICAL MIX 129
  252. BAXTER: OPERATING SEGMENTS 129
  253. BAXTER 130
  254. BAXTER: SWOT ANALYSIS 130
  255. BECTON, DICKINSON AND COMPANY: FINANCIAL REVENUE 132
  256. BECTON, DICKINSON AND COMPANY: HISTORICAL SEGMENTAL REVENUE (USD MILLION) 132
  257. BECTON, DICKINSON AND COMPANY: SEGMENTAL REVENUE 133
  258. BECTON, DICKINSON AND COMPANY: GEOGRAPHICAL REVENUE 133
  259. BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS 134
  260. BRAUN MELSUNGEN AG: RECENT FINANCIALS 136
  261. BRAUN MELSUNGEN AG: HISTORICAL SEGMENTAL REVENUE (USD MILLION) 136
  262. BRAUN MELSUNGEN AG: BUSINESS REVENUE 137
  263. BRAUN MELSUNGEN AG: GEOGRAPHICAL REVENUE 137
  264. BRAUN MELSUNGEN AG 137
  265. BRAUN MELSUNGEN AG: SWOT ANALYSIS 138
  266. FRESENIUS KABI AG: RECENT FINANCIAL 139
  267. FRESENIUS KABI AG: HISTORICAL SEGMENTAL REVENUE (USD MILLION) 140
  268. FRESENIUS KABI AG: GEOGRAPHICAL MIX 140
  269. FRESENIUS KABI AG: OPERATING SEGMENTS 141
  270. FRESENIUS KABI AG: SWOT ANALYSIS 142
  271. ICU MEDICAL, INC: RECENT FINANCIALS 143
  272. ICU MEDICAL, INC: HISTORICAL SEGMENTAL REVENUE (USD MILLION) 144
  273. ICU MEDICAL, INC: GEOGRAPHICAL MIX, 2020 (%) 144
  274. ICU MEDICAL, INC: SEGMENTAL MIX, 2020 (%) 145
  275. ICU MEDICAL, INC: SWOT ANALYSIS 146
  276. SMITH’S MEDICAL: HISTORICAL REVENUE 148
  277. SMITH’S MEDICAL: HISTORICAL SEGMENTAL REVENUE (USD MILLION) 148
  278. SMITH’S MEDICAL: SEGMENT MIX, 2020 (%) 149
  279. TERUMO MEDICAL CORPORATION FINANCIAL OVERVIEW: REVENUE & RND (%) 152
  280. TERUMO MEDICAL CORPORATION HISTORICAL SEGMENTAL REVENUE (USD MILLION) 152
  281. TERUMO MEDICAL CORPORATION FINANCIAL OVERVIEW SEGMENTAL OVERVIEW 153
  282. TERUMO MEDICAL CORPORATION FINANCIAL OVERVIEW GEOGRAPHICAL OVERVIEW 153
  283. TERUMO: SWOT ANALYSIS 154
  284. NIPRO MEDICAL CORPORATION: FINANCIAL INFORMATION 156
  285. NIPRO MEDICAL CORPORATION: GEOGRAPHICAL MIX, 2020 (%) 156
  286. NIPRO MEDICAL CORPORATION: SEGMENTAL MIX, 2020 (%) 157
  287. NIPRO MEDICAL CORPORATION: MEDICAL RELATED – PRODUCT MIX 157
  288. NIPRO MEDICAL CORPORATION: SWOT ANALYSIS 159
  289. ZYNO MEDICAL: SWOT ANALYSIS 162

Infusion System Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓